Catalyst Wire Dossier Catalyst Wire Dossier

Lovastatin/Cholesterol 2% combination

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lovastatin/Cholesterol 2% combination, covering 2023-12-07 to 2023-12-07. Get the full timeline:

Most recent: Clinical Trial Update: DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone [Phase 1]

See pricing